Therapeutic effects of selective atrioventricular node vagal stimulation in atrial fibrillation and heart failure

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 1, 2013, Pages 86-91

  Zhang, Youhua ^a   Popović, Zoran B ^a   Kusunose, Kenya ^a   Mazgalev, Todor N ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

atrial fibrillation; atrioventricular node; heart failure; rate control; vagus nerve

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ELECTRODE; EXPERIMENTAL DOG; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE PACING; IMPLANTED HEART PACEMAKER; LONG TERM CARE; NERVE STIMULATOR; NONHUMAN; PRIORITY JOURNAL; SELECTIVE ATRIOVENTRICULAR NODE VAGAL STIMULATION; VAGUS NERVE STIMULATION;

ANIMALS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; DOGS; HEART FAILURE; PACEMAKER, ARTIFICIAL; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 84871953137     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2012.02405.x     Document Type: Article

References (43)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE,: Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA 2001; 285: 2370-2375.
2. Efremidis M, Pappas L, Sideris A, Filippatos G,: Management of atrial fibrillation in patients with heart failure. J Card Fail 2008; 14: 232-237.
3. Maisel WH, Stevenson LW,: Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91: 2D-8D.
4. Lloyd-Jones D, Adams R, Carnethon M, De SG, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y,: Heart disease and stroke statistics-2009 update: A report from the american heart association statistics committee and stroke statistics subcommittee. Circulation 2009; 119: 480-486.
5. Lee DS, Mamdani MM, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV,: Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med 2004; 116: 581-589.
6. Prystowsky EN, Benson DW Jr, Fuster V, Hart RG, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG,: Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 1996; 93: 1262-1277.
7. Jung F, DiMarco JP,: Treatment strategies for atrial fibrillation. Am J Med 1998; 104: 272-286.
8. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD,: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
9. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ,: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.
10. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL,: Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358: 2667-2677.
11. Cain ME,: Atrial fibrillation-Rhythm or rate control. N Engl J Med 2002; 347: 1822-1823.
12. Falk RH,: Management of atrial fibrillation-Radical reform or modest modification? N Engl J Med 2002; 347: 1883-1884.
13. Wallick DW, Zhang Y, Tabata T, Zhuang S, Mowrey KA, Watanabe J, Greenberg NL, Grimm RA, Mazgalev TN,: Selective av nodal vagal stimulation improves hemodynamics during acute atrial fibrillation in dogs. Am J Physiol 2001; 281: H1490-H1497.
14. Zhang Y, Mowrey KA, Zhuang S, Wallick DW, Popovic ZB, Mazgalev TN,: Optimal ventricular rate slowing during atrial fibrillation by feedback AV nodal-selective vagal stimulation. Am J Physiol 2002; 282: H1102-H1110.
15. Zhuang S, Zhang Y, Mowrey KA, Li J, Tabata T, Wallick DW, Popovic ZB, Grimm RA, Natale A, Mazgalev TN,: Ventricular rate control by selective vagal stimulation is superior to rhythm regularization by atrioventricular nodal ablation and pacing during atrial fibrillation. Circulation 2002; 106: 1853-1858.
16. Schauerte P, Scherlag BJ, Scherlag MA, Goli S, Jackman WM, Lazzara R,: Ventricular rate control during atrial fibrillation by cardiac parasympathetic nerve stimulation: A transvenous approach. J Am Coll Cardiol 1999; 34: 2043-2050.
17. Schauerte P, Mischke K, Plisiene J, Waldmann M, Zarse M, Stellbrink C, Schimpf T, Knackstedt C, Sinha A, Hanrath P,: Catheter stimulation of cardiac parasympathetic nerves in humans: A novel approach to the cardiac autonomic nervous system. Circulation 2001; 104: 2430-2435.
18. Zhang Y, Yamada H, Bibevski S, Zhuang S, Mowrey KA, Wallick DW, Oh S, Mazgalev TN,: Chronic atrioventricular nodal vagal stimulation: First evidence for long-term ventricular rate control in canine atrial fibrillation model. Circulation 2005; 112: 2904-2911.
19. Mischke K, Zarse M, Schmid M, Gemein C, Hatam N, Dohmen G, Saygili E, Knackstedt C, Weis J, Pauza D, Bianchi S, Schauerte P,: Chronic augmentation of the parasympathetic tone to the atrioventricular node: A nonthoracotomy neurostimulation technique for ventricular rate control during atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 193-199.
20. Rossi P, Bianchi S, Barretta A, Della Scala A, Kornet L, De Paulis R, Bellisario A, D'Addio V, Pavaci H, Miraldi F,: Post-operative atrial fibrillation management by selective epicardial vagal fat pad stimulation. J Interv Cardiac Electrophysiol 2009; 24: 37-45.
21. Rossi P, Bianchi S, Valsecchi S, Porcelli D, Sgreccia F, Lucifiero A, Canonaco S, Campoli M, Malavasi M, Piccirillo G, Quaglione R, Azzolini P,: Endocardial vagal atrioventricular node stimulation in humans: Reproducibility on 18-month follow-up. Europace 2010; 12: 1719-1724.
22. Eckberg DL, Drabinsky M, Braunwald E,. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971; 285: 877-883.
23. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ,: Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: Demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991; 18: 464-472.
24. Shinohara T, Shen MJ, Han S, Maruyama M, Park HW, Fishbein MC, Shen C, Chen PS, Lin SF,: Heart failure decreases nerve activity in the right atrial ganglionated plexus. J Cardiovasc Electrophysiol 2012; 23: 404-412.
25. Bibevski S, Dunlap ME,: Ganglionic mechanisms contribute to diminished vagal control in heart failure. Circulation 1999; 99: 2958-2963.
26. Bibevski S, Dunlap ME,: Prevention of diminished parasympathetic control of the heart in experimental heart failure. Am J Physiol 2004; 287: H1780-H1785.
27. Zhang Y, Popovic ZB, Bibevski S, Fakhry I, Sica DA, Van Wagoner DR, Mazgalev TN,: Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2009; 2: 692-699.
28. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K,: Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109: 120-124.
29. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ,: Chronic vagus nerve stimulation: A new and promising therapeutic approach for chronic heart failure. Eur Heart J 2011; 32: 847-855.
30. Li W, Olshansky B,: Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation. Heart Fail Rev 2011; 16: 137-145.
31. Committee on Pain and Distress in Laboratory Animal: Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Recognition and assessment of pain, stress, and distress. In: Recognition and Alleviation of Pain and Distress in Laboratory Animals. Washington, DC: National Academy Press, 1992, pp. 32-52.
32. Fitzmaurice GM, Laird NM, Ware JH,: Applied Longitudinal Analysis. Hoboken, NJ: John Wiley & Sons, 2004.
33. Clark DM, Plumb VJ, Epstein AE, Kay GN,: Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997; 30: 1039-1045.
34. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, Gallagher JJ, German LD,: Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction. Am J Cardiol 1986; 57: 563-570.
35. Grogan M, Smith HC, Gersh BJ, Wood DL,: Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69: 1570-1573.
36. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B,: ACC/AHA 2005 guideline up date for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235.
37. Neuberger HR, Mewis C, van Veldhuisen DJ, Schotten U, Van Gelder IC, Allessie MA, Bohm M,: Management of atrial fibrillation in patients with heart failure. Eur Heart J 2007; 28: 2568-2577.
38. Roy D, Talajic M, Dubuc M, Thibault B, Guerra P, Macle L, Khairy P,: Atrial fibrillation and congestive heart failure. Curr Opin Cardiol 2009; 24: 29-34.
39. Ardell JL, Randall WC,: Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart. Am J Physiol 1986; 251: H764-H773.
40. Park HW, Shen MJ, Han S, Shinohara T, Maruyama M, Lee YS, Shen C, Hwang C, Chen LS, Fishbein MC, Lin SF, Chen PS,: Neural control of ventricular rate in ambulatory dogs with pacing induced sustained atrial fibrillation. Circ Arrhythm Electrophysiol 2012;5:571-580.
41. Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L,: Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96: 3450-3458.
42. Rossi P, Ricci A, De Paulis R, Papi E, Pavaci H, Porcelli D, Monari G, Maselli D, Bellisario A, Turani F, Nardella S, Azzolini P, Piccirillo G, Quaglione R, Valsecchi S, Bianchi S,: Epicardial ganglionated plexus stimulation decreases postoperative inflammatory response in humans. Heart Rhythm 2012;9:943-950.
43. Zhang Y, Mowrey KA, Bharati S, Van Wagoner DR, Mazgalev TN,: Atrioventricular nodal remodeling induced by chronic atrial fibrillation in rabbits (abstract). PACE 2003; 26: 984.